EVA

Hybridoma cell culture supernatant containing anti-SPDV antibodies; targeted antigen: envelope; clone: 12A5; immunization antigen: inactivated strain "S49P (rainbow trout)"

Genomic RNAs of Lassa virus isolates AV, Togo/2016/7082, Nig-CSF, Lib06-380 and Nig08-A37 extracted from cell culture supernatant

Anti-Middle East respiratory syndrome-related coronavirus NP protein polyclonal rabbit sera

Anti-Zaire ebola virus NP protein polyclonal rabbit sera

Anti-Nipah N polyclonal rabbit sera

rabbit polyclonal antiserum against the nucleocapsid protein (NP) of LASV

mouse monoclonal antibodies against the glycoprotein protein Gc of CCHFV

mouse monoclonal antibodies against the glycoprotein protein Gn of CCHFV

rabbit polyclonal antiserum against the glycoprotein protein Gc of CCHFV

rabbit polyclonal antiserum against the glycoprotein protein Gn of CCHFV

Real time detection kit for Zika virus targeting the envelope gene. The kit contains positive control, primers and probe for 50 reactions. Real time primers and probe were published by “Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008 Aug;14(8):1232-9.”

Hybridoma cell culture supernatant containing anti-CCHFV antibodies; targeted antigen: nucleocapsid protein; clone: 3E4B1; immunization antigen: recombinant NC protein, strain "IbAr 10200"

A panel of 11 samples, including eight extracts from phylogroup 2 & 3 lyssaviruses, RABV and two NTC's (no tissue control). The panel can be anonymised so that the laboratory does not know which RNA comes from which virus. Results will be given to the requesting laboratory on request. The panel would be good for test development and assessing staff competence. RNA from the following viruses will be included: Rabies virus, Lleida Bat Lyssavirus, Ikoma virus, Shimoni Bat virus, Mokola virus and Lagos Bat Lyssaviruses a, b, c & d.

A panel of 12 samples, including 10 RNA extract from different phylogroup 1 lyssaviruses and two NTC's (no tissue controls). The panel can be anonymised so that the receiving laboratory does not know which virus is which, results given to the receiving laboratory on request.

Hybridoma cell culture supernatant containing anti-FMDVV antibodies; targeted antigen: 3A; clone: 8H8a; immunization antigen: recombinant non-structural protein 3ABC

Hybridoma cell culture supernatant containing anti-FMDVV antibodies; targeted antigen: 3B or C; clone: 9F2; immunization antigen: recombinant non-structural protein 3ABC

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: spike protein; clone: 4H4B1; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2a

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: matrix protein; clone: 2C3B2 ; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2b

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: NP; clone: 1B6A3 ; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2b

Mouse monoclonal antibody against Zaïre Ebolavirus glycoprotein obtained in Balb/c mouse

A panel of 8 samples, including six RNA extracts from different rabies isolates and two NTC's (no tissue control). The source of the rabies isolates can be modified to meet individual needs, area/region isolated from, host species, etc. Also, the panel can be anonymised so that the receiving laboratory does not know which samples are positive and negative, the results will be given on request from the lab. The panel would be ideal for testing staff competence and proficiency.

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV4) antibodies; targeted antigen: unknown; clone: 2A9; immunization antigen: inactivated strain "1624/89"

Hybridoma cell culture supernatant containing anti-VHSV antibodies; targeted antigen: M protein; clone: 12D7; immunization antigen: inactivated strain ("DF 72/94 (Typ Wi)"

Hybridoma cell culture supernatant containing anti-EHDV antibodies; clone 10D12; immunization antigen: inactivated strain EHDV-7/ISR2006

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV5) antibodies; targeted antigen: unknown; clone: 33B9; immunization antigen: inactivated strain "F26"